Financial Ratios

HINDUSTAN BIO SCIENCES LTD.

NSE : NABSE : 532041ISIN CODE : INE597C01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE8.100 (0 %)
PREV CLOSE ( ) 8.10
OPEN PRICE ( ) 8.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6584
TODAY'S LOW / HIGH ( )8.00 8.49
52 WK LOW / HIGH ( ) 5.1515.18
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.04-0.50-0.920.080.11
   CEPS(Rs)-0.03-0.50-0.910.090.12
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)0.730.771.272.192.11
   Tax Rate(%)-6.60-0.591.6230.562.09
Margin Ratios
   Core EBITDA Margin(%)-3.06-117.53-91.137.003.73
   EBIT Margin(%)-3.67-118.32-91.916.413.44
   Pre Tax Margin(%)-4.11-119.48-92.585.993.15
   PAT Margin (%)-4.39-120.19-91.084.163.09
   Cash Profit Margin (%)-3.77-119.40-90.304.753.39
Performance Ratios
   ROA(%)-1.29-16.05-20.831.452.37
   ROE(%)-5.28-49.49-52.963.675.22
   ROCE(%)-1.10-16.66-23.702.402.68
   Asset Turnover(x)0.290.130.230.350.77
   Sales/Fixed Asset(x)1.690.791.903.586.62
   Working Capital/Sales(x)-1.65-0.75-2.582.943.52
Efficiency Ratios
   Fixed Capital/Sales(x)0.591.260.530.280.15
   Receivable days116.47318.86350.27285.28102.03
   Inventory Days0.000.000.0042.629.89
   Payable days21.18225.24255.46101.658.13
Valuation Parameters
   PER(x)0.000.000.0018.258.76
   PCE(x)-156.72-8.41-3.3016.007.98
   Price/Book(x)7.305.502.360.660.45
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)8.5615.064.771.991.16
   EV/Core EBITDA(x)-280.16-12.81-5.2328.5031.08
   EV/EBIT(x)-233.35-12.72-5.1831.1033.80
   EV/CE(x)2.412.181.410.700.74
   M Cap / Sales5.9110.052.980.760.27
Growth Ratio
   Net Sales Growth(%)114.19-58.27-46.90-45.47245.59
   Core EBITDA Growth(%)94.4346.18-791.351.96105.91
   EBIT Growth(%)93.3646.28-860.911.62105.41
   PAT Growth(%)92.1844.93-1262.13-26.46104.83
   EPS Growth(%)92.1844.93-1262.13-26.46104.83
Financial Stability Ratios
   Total Debt/Equity(x)3.292.751.421.161.56
   Current Ratio(x)0.610.480.721.402.02
   Quick Ratio(x)0.610.480.721.191.91
   Interest Cover(x)-8.26-102.33-138.0315.2311.86
   Total Debt/Mcap(x)0.450.500.601.763.49

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.